These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33112417)

  • 1. Intranasal oxytocin as a treatment for chronic pelvic pain: A randomized controlled feasibility study.
    Flynn MJ; Campbell TS; Robert M; Nasr-Esfahani M; Rash JA
    Int J Gynaecol Obstet; 2021 Mar; 152(3):425-432. PubMed ID: 33112417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for a placebo-controlled, within-participants crossover trial evaluating the efficacy of intranasal oxytocin to improve pain and function among women with chronic pelvic musculoskeletal pain.
    Rash JA; Toivonen K; Robert M; Nasr-Esfahani M; Jarrell JF; Campbell TS
    BMJ Open; 2017 Apr; 7(4):e014909. PubMed ID: 28416501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of long-term intranasal oxytocin on sexual dysfunction in premenopausal and postmenopausal women: a randomized trial.
    Muin DA; Wolzt M; Marculescu R; Sheikh Rezaei S; Salama M; Fuchs C; Luger A; Bragagna E; Litschauer B; Bayerle-Eder M
    Fertil Steril; 2015 Sep; 104(3):715-23.e4. PubMed ID: 26151620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the efficacy of intranasal oxytocin on pain and function among individuals who experience chronic pain: a protocol for a multisite, placebo-controlled, blinded, sequential, within-subjects crossover trial.
    Rash JA; Campbell TS; Cooper L; Flusk D; MacInnes A; Nasr-Esfahani M; Mekhael AA; Poulin PA; Robert M; Yi Y
    BMJ Open; 2021 Sep; 11(9):e055039. PubMed ID: 34556520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-specific effects of intranasal oxytocin on thermal pain perception: A randomised, double-blind, placebo-controlled cross-over study.
    Tracy LM; Labuschagne I; Georgiou-Karistianis N; Gibson SJ; Giummarra MJ
    Psychoneuroendocrinology; 2017 Sep; 83():101-110. PubMed ID: 28601750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of intranasal oxytocin administration on acute cold pressor pain: a placebo-controlled, double-blind, within-participants crossover investigation.
    Rash JA; Campbell TS
    Psychosom Med; 2014; 76(6):422-9. PubMed ID: 24979580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitigation of sociocommunicational deficits of autism through oxytocin-induced recovery of medial prefrontal activity: a randomized trial.
    Watanabe T; Abe O; Kuwabara H; Yahata N; Takano Y; Iwashiro N; Natsubori T; Aoki Y; Takao H; Kawakubo Y; Kamio Y; Kato N; Miyashita Y; Kasai K; Yamasue H
    JAMA Psychiatry; 2014 Feb; 71(2):166-75. PubMed ID: 24352377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent social-cognitive effects of intranasal oxytocin delivered with novel Breath Powered device in adults with autism spectrum disorder: a randomized placebo-controlled double-blind crossover trial.
    Quintana DS; Westlye LT; Hope S; Nærland T; Elvsåshagen T; Dørum E; Rustan Ø; Valstad M; Rezvaya L; Lishaugen H; Stensønes E; Yaqub S; Smerud KT; Mahmoud RA; Djupesland PG; Andreassen OA
    Transl Psychiatry; 2017 May; 7(5):e1136. PubMed ID: 28534875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxytocin-induced increase in N,N-dimethylglycine and time course of changes in oxytocin efficacy for autism social core symptoms.
    Kato Y; Kuwabara H; Okada T; Munesue T; Benner S; Kuroda M; Kojima M; Yassin W; Eriguchi Y; Kameno Y; Murayama C; Nishimura T; Tsuchiya K; Kasai K; Ozaki N; Kosaka H; Yamasue H
    Mol Autism; 2021 Feb; 12(1):15. PubMed ID: 33622389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal oxytocin reduces heart rate variability during a mental arithmetic task: A randomised, double-blind, placebo-controlled cross-over study.
    Tracy LM; Gibson SJ; Labuschagne I; Georgiou-Karistianis N; Giummarra MJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():408-415. PubMed ID: 28844717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxytocin for frontotemporal dementia: a randomized dose-finding study of safety and tolerability.
    Finger EC; MacKinley J; Blair M; Oliver LD; Jesso S; Tartaglia MC; Borrie M; Wells J; Dziobek I; Pasternak S; Mitchell DG; Rankin K; Kertesz A; Boxer A
    Neurology; 2015 Jan; 84(2):174-81. PubMed ID: 25503617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: a randomized clinical trial.
    Yamasue H; Okada T; Munesue T; Kuroda M; Fujioka T; Uno Y; Matsumoto K; Kuwabara H; Mori D; Okamoto Y; Yoshimura Y; Kawakubo Y; Arioka Y; Kojima M; Yuhi T; Owada K; Yassin W; Kushima I; Benner S; Ogawa N; Eriguchi Y; Kawano N; Uemura Y; Yamamoto M; Kano Y; Kasai K; Higashida H; Ozaki N; Kosaka H
    Mol Psychiatry; 2020 Aug; 25(8):1849-1858. PubMed ID: 29955161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intranasal oxytocin on thermal pain in healthy men: a randomized functional magnetic resonance imaging study.
    Zunhammer M; Geis S; Busch V; Greenlee MW; Eichhammer P
    Psychosom Med; 2015; 77(2):156-66. PubMed ID: 25647754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxytocin-enhanced motivational interviewing group therapy for methamphetamine use disorder in men who have sex with men: study protocol for a randomized controlled trial.
    Stauffer CS; Moschetto JM; McKernan SM; Hsiang E; Borsari B; Woolley JD
    Trials; 2019 Feb; 20(1):145. PubMed ID: 30791944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of ASP1707 for endometriosis-associated pelvic pain: the phase II randomized controlled TERRA study.
    D'Hooghe T; Fukaya T; Osuga Y; Besuyen R; López B; Holtkamp GM; Miyazaki K; Skillern L
    Hum Reprod; 2019 May; 34(5):813-823. PubMed ID: 31067329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxytocin nasal spray in fibromyalgic patients.
    Mameli S; Pisanu GM; Sardo S; Marchi A; Pili A; Carboni M; Minerba L; Trincas G; Carta MG; Melis MR; Agabio R
    Rheumatol Int; 2014 Aug; 34(8):1047-52. PubMed ID: 24509894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled clinical trial of 8-week intranasal oxytocin administration in adults with obesity: Rationale, study design, and methods.
    Wronski ML; Plessow F; Kerem L; Asanza E; O'Donoghue ML; Stanford FC; Bredella MA; Torriani M; Soukas AA; Kheterpal A; Eddy KT; Holmes TM; Deckersbach T; Vangel M; Holsen LM; Lawson EA
    Contemp Clin Trials; 2022 Nov; 122():106909. PubMed ID: 36087842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intranasal oxytocin on alcohol withdrawal syndrome: A randomized placebo-controlled double-blind clinical trial.
    Melby K; Gråwe RW; Aamo TO; Salvesen Ø; Spigset O
    Drug Alcohol Depend; 2019 Apr; 197():95-101. PubMed ID: 30784955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal Oxytocin to Prevent Posttraumatic Stress Disorder Symptoms: A Randomized Controlled Trial in Emergency Department Patients.
    van Zuiden M; Frijling JL; Nawijn L; Koch SBJ; Goslings JC; Luitse JS; Biesheuvel TH; Honig A; Veltman DJ; Olff M
    Biol Psychiatry; 2017 Jun; 81(12):1030-1040. PubMed ID: 28087128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No side-effects of single intranasal oxytocin administration in middle childhood.
    Verhees MWFT; Houben J; Ceulemans E; Bakermans-Kranenburg MJ; van IJzendoorn MH; Bosmans G
    Psychopharmacology (Berl); 2018 Aug; 235(8):2471-2477. PubMed ID: 29915962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.